0001209191-23-037604.txt : 20230615
0001209191-23-037604.hdr.sgml : 20230615
20230615201752
ACCESSION NUMBER: 0001209191-23-037604
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chung Christine
CENTRAL INDEX KEY: 0001775295
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 231019112
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-13
0
0000921299
FIBROGEN INC
FGEN
0001775295
Chung Christine
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO
CA
94158
0
1
0
0
SVP, China Operations
1
Common Stock
2023-06-13
4
S
0
6250
17.60
D
242577
D
Common Stock
2023-06-14
4
S
0
5250
16.66
D
237327
D
Common Stock
2023-06-14
4
S
0
1000
17.46
D
236327
D
Shares sold pursuant to a 10b5-1 trading plan.
The shares were sold at prices ranging from $17.31 to $18.18. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares were sold at prices ranging from $16.34 to $17.32. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares were sold at prices ranging from $17.37 to $17.61. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
2023-06-15